Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

siemens healthineers ag - SMMNY

SMMNY

Close Chg Chg %
24.80 0.13 0.52%

Closed Market

24.93

+0.13 (0.52%)

Volume: 76.14K

Last Updated:

Feb 6, 2026, 3:58 PM EDT

Trade Now

Company Overview: siemens healthineers ag - SMMNY

SMMNY Key Data

Open

$25.01

 Day Range

24.71 - 25.15

52 Week Range

23.28 - 30.19

 Market Cap

$56.38B

Shares Outstanding

2.23B

 Public Float

N/A

Beta

1.07

 Rev. Per Employee

N/A

P/E Ratio

23.52

 EPS

$1.07

Yield

117.71%

 Dividend

$0.35

EX-DIVIDEND DATE

Feb 9, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

99.61K

  

SMMNY Performance

1 Week
 
 -0.32%
 
1 Month
 
 -7.80%
 
3 Months
 
 -0.32%
 
1 Year
 
 -13.86%
 
5 Years
 
 -16.73%
 

SMMNY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About siemens healthineers ag - SMMNY

Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.

SMMNY At a Glance

Siemens Healthineers AG
Siemensstr. 3
Forchheim, Bayern (Bavaria) 91301
Phone 49-9131-84-3385 Revenue 25.81B
Industry Medical Specialties Net Income 2.37B
Sector Health Technology 2025 Sales Growth 6.461%
Fiscal Year-end 09 / 2026 Employees 74,000
View SEC Filings

SMMNY Valuation

P/E Current 23.519
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 25.581
Price to Sales Ratio 2.357
Price to Book Ratio 2.849
Price to Cash Flow Ratio 17.87
Enterprise Value to EBITDA 14.555
Enterprise Value to Sales 2.946
Total Debt to Enterprise Value 0.233

SMMNY Efficiency

Revenue/Employee 348,742.079
Income Per Employee 31,987.295
Receivables Turnover 3.023
Total Asset Turnover 0.499

SMMNY Liquidity

Current Ratio 1.115
Quick Ratio 0.788
Cash Ratio 0.172

SMMNY Profitability

Gross Margin 38.631
Operating Margin 14.695
Pretax Margin 12.248
Net Margin 9.172
Return on Assets 4.573
Return on Equity 11.405
Return on Total Capital 6.086
Return on Invested Capital 6.777

SMMNY Capital Structure

Total Debt to Total Equity 83.492
Total Debt to Total Capital 45.502
Total Debt to Total Assets 33.946
Long-Term Debt to Equity 62.871
Long-Term Debt to Total Capital 34.264
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Siemens Healthineers Ag - SMMNY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
23.48B 23.11B 24.24B 25.81B
Sales Growth
+9.20% -1.59% +4.90% +6.46%
Cost of Goods Sold (COGS) incl D&A
14.68B 14.89B 15.06B 15.84B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.45B 1.66B 1.33B 1.43B
Depreciation
811.06M 863.36M 792.38M 874.40M
Amortization of Intangibles
641.28M 796.21M 533.31M 556.44M
COGS Growth
+11.25% +1.42% +1.14% +5.15%
Gross Income
8.80B 8.22B 9.18B 9.97B
Gross Income Growth
+5.93% -6.62% +11.71% +8.61%
Gross Profit Margin
+37.47% +35.56% +37.87% +38.63%
2022 2023 2024 2025 5-year trend
SG&A Expense
5.49B 5.62B 5.60B 6.18B
Research & Development
1.93B 1.99B 2.08B 2.16B
Other SG&A
3.56B 3.63B 3.52B 4.02B
SGA Growth
+9.97% +2.37% -0.25% +10.27%
Other Operating Expense
- - - -
-
Unusual Expense
129.77M 217.44M 467.19M 276.01M
EBIT after Unusual Expense
3.18B 2.38B 3.11B 3.52B
Non Operating Income/Expense
(30.28M) (15.99M) 143.08M 113.72M
Non-Operating Interest Income
51.91M 90.60M 128.99M 109.30M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
127.61M 315.50M 515.97M 469.22M
Interest Expense Growth
+28.67% +147.24% +63.54% -9.06%
Gross Interest Expense
127.61M 315.50M 515.97M 469.22M
Interest Capitalized
- - - -
-
Pretax Income
3.03B 2.05B 2.74B 3.16B
Pretax Income Growth
+5.60% -32.19% +33.39% +15.49%
Pretax Margin
+12.89% +8.88% +11.29% +12.25%
Income Tax
806.74M 429.55M 611.35M 756.27M
Income Tax - Current - Domestic
1.09B 712.01M 832.48M 1.09B
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(287.66M) (282.46M) (221.13M) (333.42M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.22B 1.63B 2.12B 2.39B
Minority Interest Expense
18.38M 17.05M 18.43M 26.50M
Net Income
2.20B 1.61B 2.11B 2.37B
Net Income Growth
+6.75% -26.99% +30.88% +12.45%
Net Margin Growth
+9.38% +6.96% +8.68% +9.17%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.20B 1.61B 2.11B 2.37B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.20B 1.61B 2.11B 2.37B
EPS (Basic)
0.9814 0.7184 0.9413 1.0569
EPS (Basic) Growth
+4.59% -26.80% +31.03% +12.28%
Basic Shares Outstanding
2.25B 2.24B 2.24B 2.24B
EPS (Diluted)
0.9771 0.7158 0.9369 1.0523
EPS (Diluted) Growth
+4.51% -26.74% +30.89% +12.32%
Diluted Shares Outstanding
2.26B 2.25B 2.25B 2.25B
EBITDA
4.77B 4.26B 4.90B 5.22B
EBITDA Growth
+4.52% -10.61% +15.08% +6.54%
EBITDA Margin
+20.30% +18.44% +20.23% +20.24%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 32.175
Number of Ratings 21 Current Quarters Estimate 0.307
FY Report Date 03 / 2026 Current Year's Estimate 1.364
Last Quarter’s Earnings 0.289 Median PE on CY Estimate N/A
Year Ago Earnings 1.372 Next Fiscal Year Estimate 1.556
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 20 19
Mean Estimate 0.31 0.34 1.36 1.56
High Estimates 0.33 0.37 1.44 1.65
Low Estimate 0.29 0.33 1.28 1.47
Coefficient of Variance 5.71 4.45 2.69 3.04

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 15
OVERWEIGHT 2 2 2
HOLD 6 6 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Siemens Healthineers Ag in the News